Continued Pressure for Alveolar Protection (CPAP Trial)
Recruiting
N/A
Interventional Study
Bronchopulmonary Dysplasia (BPD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- Up to 31 Weeks
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 860 (estimated)
- Sponsor
- NICHD Neonatal Research Network · Research network
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of the CPAP Trial is to test whether extending CPAP until 34 weeks' PMA or for at least 2 additional weeks compared to weaning to a nasal canula will decrease the likelihood of bronchopulmonary dysplasia or death at 36 weeks' PMA.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Gestational age \<29 weeks at birth
* PMA \<32 weeks at study entry
* On treatment with CPAP without a rate in FiO2 \<0.25 and PEEP of 4-5 cmH2O
* Meet stability criteria:
* If previously intubated must be extubated ≥ 72 hours
* \<3 self-resolving apneas (≤ 20 s) and/or bradyc…
Contacts